Systematic Reviews
Copyright
©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Meta-Anal. Apr 26, 2016; 4(2): 10-43
Published online Apr 26, 2016. doi: 10.13105/wjma.v4.i2.10
Table 1 Selected details of the 102 studies in publication date order
Study ref Main ref Other ref Location Study design1 Study dates2 Total cases Never smoker criteria3 GARFI1 [75] [104] United States P 1959 - 1960, 1971 153 Dur 6 mo CHAN [105] [106,107] Hong Kong CC 1976 - 1977 84 CORREA [67] United States CC 1979 - 1982 32 TRICHO [27] [108,109] Greece CC 1978 - 1982 77 BUFFLE [110] United States CC 1976 - 1980 52 HIRAYA [28] [111-120] Japan P 1965 - 1966, 1981 264 KABAT1 [53] United States CC 1971 - 1980 76 GARFI2 [121] [122] United States CC 1971 - 1981 134 LAMW [29] Hong Kong CC 1981 - 1984 75 WU [123] United States CC 1981 - 1982 31 AKIBA [68] Japan CC 1971 - 1980 113 LEE [124] United Kingdom CC 1979 - 1982 47 BROWN1 [125] United States CC 1979 - 1982 19 GAO [126] China CC 1984 - 1986 246 HUMBL1 [127] United States CC 1980 - 1984 28 Dur 6 mo KOO [128] [129-133] Hong Kong CC 1981 - 1983 88 N20 LAMT [30] Hong Kong CC 1983 - 1986 199 Occ (1 yr) PERSHA [134] [135] Sweden CC 1961 - 1980 77 BUTLER [136] United States P 1976 - 1976, 1982 8 GENG [31] [137] China CC 1983 - 1983 54 INOUE [138] Japan CC 1973 - 1983 28 SHIMIZ [70] Japan CC 1982 - 1985 90 CHOI [139] South Korea CC 1985 - 1988 88 HOLE [140] [141] Scotland P 1972 - 1976, 1985 9 SCHOEN [142] United States CC 1982 - 1983 116 SVENSS [143] [144] Sweden CC 1983 - 1985 34 Occ JANERI [72] [145] United States CC 1982 - 1985 191 N100 KALAND [32] Greece CC 1987 - 1989 91 SOBUE [146] [147] Japan CC 1986 - 1988 144 WU-WIL [46] China CC 1985 - 1987 417 LIUZ [148] [149,150] China CC 1985 - 1986 54 1sm BROWN2 [151] [152-155] United States CC 1986 - 1991 432 STOCKW [58] [156] United States CC 1987 - 1991 210 N100, Dur 6 mo DU [52] [157-159] China CC 1986 - 1986 75 LIUQ [160] China CC 1983 - 1984 38 FONTHA [33] [161-164] United States CC 1986 - 1988 653 N100, Dur 6 mo LAYARD [165] United States CC 1986 - 1986 60 DEWAAR [166] [167] Netherlands CC 1977 - 1991 23 Cot KABAT2 [168] [169,170] United States CC 1983 - 1990 110 SCHWAR [57] United States CC 1984 - 1987 257 SUN [60] China CC NA 230 WANGS [34] China CC NA 82 WANGT [171] China CC 1992 - 1994 135 CARDEN [73] [172,173] United States P 1982 - 1982, 1989 362 ZHENG [35] China CC 1990 - 1993 94 Non AUVINE [174] Finland CC 1986 - 1992 44 BOFFET [66] [175-180] West Europe CC 1988 - 1994 640 N400 SHEN [181] [182-185] China CC 1993 - 1993 70 ZARIDZ [36] [186-188] Russia CC 1991 - 1993 189 BOFFE2 [189] Europe CC 1994 - 1996 70 N400 JEE [190] South Korea P 1992 - 1994, 1997 79 Occ, Dur 1 yr RAPITI [61] India CC 1991 - 1992 58 N400 SPEIZE [191] United States P 1982 - 1982, 1992 35 ZHONG [54] China CC 1992 - 1994 504 Dur 6 mo LEECH [37] [192-194] Taiwan CC 1992 - 1998 268 N400 MALATS [195] [196] Europe/Brazil CC NA 122 Occ WANGL [62] [197] China CC 1994 - 1998 233 Dur 6 mo JOHNSO [198] [199-201] Canada CC 1994 - 1997 71 N100 LAGARD [202] [203] Sweden CC 1980 - 1995 433 Occ (1 yr) NISHIN [204] Japan P 1984 - 1984, 1992 24 OHNO [205] Japan CC NA 191 N365 RACHTA [63] [206] Poland CC 1991 - 1997 54 Dur 6 mo ENSTRO [207] [208] United States P 1959 - 1960, 1998 256 ZATLOU [64] [209,210] Czech Republic CC 1998 - 2002 84 N100 IARCKR [1] [180] Germany CC 1990 - 1996 123 Dur 6 mo, N400 MCGHEE [211] Hong Kong CC 1998 - 1998 324 EPICA [212] [213-216] Western Europe P 1993 - 1998, 2000 59 FANG [38] [216] China CC 2001 - 2004 157 FRANCO [71] [216] Mexico CC 2000 - 2002 94 GORLOV [55] [217-222] United States CC 1995 - 2003 193 N100 NEUBER [49] United States CC 1994 - 1997 56 N100, Dur 6 mo RYLAND [223] Sweden CC 1989 - 1994 49 WEN [56] [224-227] China P 1997 - 2000, 2004 106 YU [228] [228-230] Hong Kong CC 2002 - 2004 213 N400, Dur 1 yr ZEKA [59] East Europe, United Kingdom CC 1998 - 2002 223 N100 HILL1 [231] New Zealand P 1981 - 1981, 1984 147 Occ HILL2 [231] New Zealand P 1996 - 1996, 1999 234 Occ LOPEZC [232] Spain CC 2000 - 2005 36 N100 ASOMAN [233] United States CC 1992 - NA 138 Occ (1 yr) GALLEG [51] Mexico CC 2003 - 2007 32 KURAHA [234] Japan P 1990 - 1993, 2004 109 PANDEY [50] Nepal CC NA 268 YANG [39] [65,221,235,236] United States CC 1997 - 2008 297 N100 OLIVOM [65] [237] United States CC NA 45 N100 TSE [238] [239] China CC 2004 - 2006 132 N400, Dur 1 yr LIANG [40] China CC 2004 - 2007 226 BRENNE [47] Canada CC 1997 - 2002 156 N100 JIANG [41] China CC 2009 - 2009 145 EPICC [240] [212] Western Europe P 1992 - 1998, 2006 98 KIYOHA [241] Japan CC 1996 - 2008 153 HE [242] [243] China P 1976 - 1994, 2011 16 N100 LIM [74] [244-246] China CC 1996 - 2008 433 Occ (1 yr) LIN [42] China CC 2006 - 2010 226 FERREC [247] Chile CC 2007 - 2010 59 ALZOUG [48] [248,249] Canada CC 1996 - 2000 44 N100 GELAC [43] Taiwan CC 2002 - 2009 1540 Occ MASJED [44] [250] Iran CC 2002 - 2005 81 Dur 6 mo REN [251] China CC 2002 - 2012 764 SEKI [252] Japan CC 1997 - 2009 431 WHIOS [253] [254] United States P 1993 - 1998, 2009 200 ILCCO [45] [69] International CC 1984 - 2014 2504 N100 TORRES [255] [256] Spain CC 2011 - 2013 192 N100
Table 2 Further details of the 102 studies
Ref. ETS exposures1 Adjustment variables used2 Extent (%) of histological confirmation Results by histological type Dose-response results available3 GARFI1 s 7 NA Yes CHAN s 0 80 CORREA s c4 1 97 Yes TRICHO s 0 27 Yes Yes BUFFLE h 0 100 Yes HIRAYA s 2 NA Yes KABAT1 s h w 4 100 GARFI2 s h w c o tot 4 100 Yes Yes LAMW s tot 1 100 Yes WU s w c tot4 2 100 Yes AKIBA s c 6 53 Yes LEE s h w tr o tot 3 38 Yes BROWN1 tot 3 100 Yes GAO s h c tot 2 43 Yes HUMBL1 s 2 100 Yes KOO s h w c tot 5 97 Yes Yes LAMT s 0 100 Yes Yes PERSHA s c 2 83 Yes Yes BUTLER s 2 100 GENG s 0 85 Yes INOUE s 3 NA Yes SHIMIZ s h w 3 100 CHOI s 0 100 Yes HOLE h 2 NA Yes SCHOEN s 6 100 SVENSS h c tot 1 70 JANERI s h w c o 3 100 Yes Yes KALAND s h w 5 48 Yes Yes SOBUE s h c 3 100 WU-WIL s h w c 5 42 LIUZ h 3 17 BROWN2 s h w c 2 76 Yes Yes STOCKW s h w4 c o4 tot 3 100 Yes Yes DU s 2 NA Yes LIUQ s 3 32 Yes FONTHA s h w c o tot 10 100 Yes Yes LAYARD s 3 NA Yes DEWAAR tot 0 71 Yes KABAT2 s h w c tr o tot 6 100 Yes SCHWAR h w 2 100 SUN s h w c hw tot 2 100 Yes WANGS tot 0 100 WANGT s w c 1 57 Yes CARDEN s h w o tot 8 NA Yes ZHENG h 2 82 Yes Yes AUVINE tot 1 NA BOFFET s h w c tr o tot 7 96 Yes Yes SHEN tot 9 100 Yes Yes ZARIDZ s h w c 2 100 Yes Yes BOFFE2 s w c tot 5 100 Yes Yes JEE s 5 0 Yes RAPITI s w c tr 3 100 Yes Yes SPEIZE tot 1 100 ZHONG s h w c tot 7 57 Yes Yes LEECH s h w c tot 7 100 Yes MALATS s tot 2 100 Yes WANGL h c 6 32 Yes JOHNSO h w c tot 4 100 Yes LAGARD h tot 6 100 NISHIN s h 7 NA OHNO s w c tr o tot 2 100 Yes RACHTA c 21 100 Yes ENSTRO s 8 NA ZATLOU c tot 3 100 Yes IARCKR s w c 2 100 Yes MCGHEE h 2 0 Yes EPICA h w tot 7 NA FANG tot 8 100 Yes FRANCO h 2 100 GORLOV h w hw tot 4 100 NEUBER tot4 3 100 RYLAND h w 3 98 WEN s w c tot 9 NA Yes YU tot 20 100 Yes ZEKA w 4 NA Yes HILL1 h 9 NA HILL2 h 9 NA LOPEZC tot 0 100 ASOMAN h w o 0 100 GALLEG tot 0 100 KURAHA s w c hw tot 5 90 Yes Yes PANDEY c tot 0 NA Yes YANG c tot 5 NA OLIVOM c 4 100 Yes TSE h w tot 9 100 Yes Yes LIANG c tot 0 100 BRENNE h w c tot 3 100 Yes JIANG tot 17 100 Yes EPICC c 10 NA Yes KIYOHA s 0 100 HE tot 9 88 Yes LIM h 0 96 LIN tot 9 100 Yes FERREC c tot4 3 72 ALZOUG s h w c tot 3 NA Yes Yes GELAC s h w hw tot 6 100 Yes MASJED s h w o tot 4 100 Yes REN tot 5 100 SEKI s 7 94 Yes WHIOS h4 w4 c4 tot 0 0 4 ILCCO h w c tot 3 100 Yes Yes TORRES h 2 99 Yes
Table 3 Meta-analyses of smoking by the spouse (or nearest equivalent)
Estimates considered No. of estimates Relative risk (95% confidence limits) Heterogeneity1 Fixed-effects meta-analysis Random-effects meta-analysis All 119 1.18 (1.14-1.23) 1.21 (1.14-1.29) +++ N America 38 1.08 (1.00-1.17) 1.09 (0.95-1.26) +++ Europe 22 1.15 (1.03-1.28) 1.16 (1.00-1.35) (+) Asia 54 1.24 (1.17-1.32) 1.31 (1.20-1.44) +++ Asia - Japan 13 1.26 (1.11-1.45) 1.26 (1.11-1.45) NS Asia - Hong Kong 8 1.32 (1.12-1.57) 1.31 (1.06-1.63) NS Asia - China 23 1.16 (1.06-1.27) 1.29 (1.08-1.54) +++ Asia - Other 10 1.34 (1.19-1.51) 1.37 (1.19-1.57) NS Heterogeneity between Asian countries NS Other continents 5 1.20 (1.09-1.33) 1.20 (1.09-1.33) NS Heterogeneity between continents (+) Published in 1981-1989 34 1.38 (1.24-1.54) 1.38 (1.24-1.54) NS Published in 1990-1999 33 1.09 (1.01-1.17) 1.15 (1.02-1.28) ++ Published in 2000-2009 34 1.22 (1.12-1.33) 1.21 (1.08-1.36) + Published in 2010 onwards 18 1.17 (1.10-1.26) 1.13 (0.94-1.36) +++ Heterogeneity by publication date ++ 1-49 cases 23 1.44 (1.14-1.81) 1.47 (1.15-1.88) NS 50-99 31 1.30 (1.14-1.47) 1.27 (1.08-1.50) + 100-199 29 1.09 (1.00-1.19) 1.10 (0.96-1.26) +++ 200-399 22 1.33 (1.21-1.46) 1.32 (1.16-1.50) + 400+ 14 1.14 (1.07-1.20) 1.13 (1.02-1.25) ++ Heterogeneity by study size ++ Case-control 97 1.18 (1.13-1.23) 1.22 (1.13-1.31) +++ Prospective 22 1.18 (1.05-1.33) 1.18 (1.05-1.33) NS Heterogeneity by study type NS Not age adjusted 21 1.34 (1.19-1.50) 1.42 (1.18-1.71) + Age adjusted 98 1.16 (1.11-1.21) 1.18 (1.10-1.26) +++ Heterogeneity by age adjustment NS Dose-response results not reported 46 1.13 (1.06-1.21) 1.18 (1.06-1.31) ++ Only no dose-response stated 2 0.95 (0.60-1.50) 0.95 (0.60-1.50) NS Dose-response results reported 71 1.21 (1.15-1.28) 1.24 (1.14-1.35) +++ Heterogeneity by dose response reporting NS Spouse the index 71 1.18 (1.11-1.24) 1.21 (1.12-1.31) ++ Spouse not the index 48 1.19 (1.12-1.27) 1.20 (1.07-1.35) +++ Heterogeneity by index definition NS
Table 4 Meta-analyses of childhood environmental tobacco smoke exposure
Estimates considered No. of estimates Relative risk (95% confidence limits) Heterogeneity1 Fixed-effects meta-analysis Random-effects meta-analysis From any cohabitant 41 1.08 (1.01-1.15) 1.15 (1.02-1.29) +++ N America 13 1.00 (0.89-1.13) 1.06 (0.89-1.28) + Europe 11 0.94 (0.81-1.08) 1.02 (0.81-1.29) + Asia 15 1.26 (1.11-1.42) 1.31 (1.02-1.67) +++ Other 2 1.10 (0.95-1.28) 1.13 (0.89-1.45) NS Heterogeneity between continents + From mother specifically 9 0.96 (0.77-1.20) 0.98 (0.77-1.25) NS From father specifically 11 0.90 (0.80-1.00) 1.00 (0.78-1.29) +++ From parents specifically 8 0.78 (0.64-0.94) 0.78 (0.64-0.94) NS
Table 5 Estimates used when adjusting for potential confounding effects1
Statistic Fruit consumption Vegetable consumption Dietary fat consumption Education Lung cancer risk N studies 14 16 6 12 RR2 0.86 0.88 1.22 0.91 (95%CI) (0.78-0.96)8 (0.80-0.97)8 (1.09-1.36)8 (0.88-0.95)6 per SD SD SD Year3 ETS exposure N studies 11 16 12 13 at home Difference2 4 -0.0737 -0.0568 0.1317 -0.5346 (SE) -0.02 -0.021 -0.032 -0.063 unit SD SD SD Year3 Correlations5 Fruit consumption 1 +0.3147 -0.104NS +0.143NS Vegetable consumption 1 -0.054NS -0.1309 Dietary fat consumption 1 -0.039NS Education 1
Table 6 Adjusted/corrected analyses: Husband smoking1
Studies n Unadjusted for confounding Uncorrected for misclassification RR (95%CI) Adjusted for confounding2 Uncorrected for misclassification RR (95%CI) Adjusted for confounding2 Corrected for misclassification3 RR (95%CI) All 93 1.219 (1.138-1.305) 1.139 (1.062-1.221) 1.077 (0.999-1.162) North America 29 1.074 (0.937-1.232) 1.004 (0.873-1.154) 0.898 (0.775-1.039) Europe and New Zealand 20 1.174 (1.007-1.369) 1.092 (0.934-1.277) 1.062 (0.899-1.254) China (including Hong Kong and study LIM) 27 1.321 (1.144-1.524) 1.239 (1.071-1.433) 1.175 (1.005-1.374) Rest of Asia (including study ILCCO) 17 1.284 (1.187-1.389) 1.194 (1.103-1.291) 1.164 (1.072-1.262) North America, Europe and New Zealand 49 1.112 (1.004-1.231) 1.037 (0.935-1.150) 0.959 (0.858-1.072) Asia 44 1.314 (1.199-1.439) 1.229 (1.121-1.348) 1.181 (1.070-1.304) Published in 1980s 26 1.361 (1.216-1.522) 1.267 (1.132-1.417) 1.194 (1.059-1.347) Published in 1990s 27 1.152 (1.016-1.305) 1.077 (0.948-1.225) 1.005 (0.871-1.160) Published in 2000s 26 1.240 (1.105-1.392) 1.163 (1.034-1.308) 1.115 (0.987-1.260) Published in 2010s 14 1.139 (0.945-1.372) 1.059 (0.877-1.277) 1.026 (0.844-1.247) < 100 cases 49 1.339 (1.178-1.521) 1.249 (1.098-1.422) 1.192 (1.038-1.370) 100-199 cases 22 1.117 (0.973-1.284) 1.042 (0.904-1.200) 0.978 (0.846-1.131) 200-399 cases 13 1.363 (1.190-1.561) 1.275 (1.114-1.460) 1.226 (1.051-1.429) 400+ cases 9 1.101 (0.973-1.247) 1.027 (0.905-1.166) 0.957 (0.826-1.108) With dose-response data4 24 1.308 (1.181-1.449) 1.226 (1.105-1.359) 1.170 (1.052-1.302) Without dose-response data 69 1.182 (1.088-1.286) 1.104 (1.014-1.201) 1.040 (0.948-1.141) With age adjustment5 75 1.184 (1.100-1.274) 1.106 (1.027-1.191) 1.048 (0.966-1.136) Without age adjustment 18 1.437 (1.194-1.728) 1.340 (1.110-1.618) 1.264 (1.026-1.556) Case-control studies 77 1.226 (1.133-1.326) 1.144 (1.057-1.239) 1.080 (0.990-1.177) Prospective studies 16 1.187 (1.043-1.350) 1.111 (0.977-1.264) 1.064 (0.928-1.220)
Table 7 Adjusted/corrected analyses: Per 10 cigs smoked by husband1
Studies n Unadjusted for confounding Uncorrected for misclassification RR (95%CI) Adjusted for confounding2 Uncorrected for misclassification RR (95%CI) Adjusted for confounding2 Corrected for misclassification3 RR (95%CI) All 93 1.102 (1.065-1.140) 1.062 (1.027-1.099) 1.032 (0.994-1.071) North America 29 1.037 (0.977-1.101) 1.006 (0.946-1.070) 0.957 (0.896-1.022) Europe and New Zealand 20 1.060 (0.995-1.128) 1.020 (0.956-1.088) 1.003 (0.938-1.073) China (including Hong Kong and study LIM) 27 1.169 (1.082-1.263) 1.127 (1.041-1.219) 1.094 (1.006-1.191) Rest of Asia (including study ILCCO) 17 1.142 (1.095-1.191) 1.094 (1.050-1.141) 1.079 (1.033-1.127) North America, Europe and New Zealand 49 1.046 (1.001-1.094) 1.012 (0.967-1.059) 0.974 (0.928-1.023) Asia 44 1.158 (1.104-1.216) 1.113 (1.060-1.170) 1.089 (1.033-1.147) Published in 1980s 26 1.148 (1.092-1.207) 1.105 (1.052-1.162) 1.075 (1.019-1.134) Published in 1990s 27 1.063 (1.004-1.125) 1.025 (0.967-1.087) 0.988 (0.926-1.053) Published in 2000s 26 1.123 (1.056-1.194) 1.085 (1.020-1.155) 1.061 (0.995-1.132) Published in 2010s 14 1.073 (0.970-1.188) 1.032 (0.932-1.143) 1.014 (0.912-1.128) < 100 cases 49 1.143 (1.077-1.213) 1.101 (1.036-1.169) 1.072 (1.005-1.144) 100-199 cases 22 1.062 (0.993-1.137) 1.025 (0.957-1.098) 0.994 (0.926-1.066) 200-399 cases 13 1.176 (1.097-1.261) 1.134 (1.058-1.216) 1.111 (1.027-1.202) 400+ cases 9 1.041 (0.976-1.111) 1.002 (0.938-1.070) 0.966 (0.895-1.042) With dose-response data4 24 1.123 (1.072-1.176) 1.082 (1.032-1.134) 1.053 (1.005-1.103) Without dose-response data 69 1.091 (1.044-1.139) 1.053 (1.007-1.100) 1.021 (0.973-1.071) With age adjustment5 75 1.084 (1.046-1.123) 1.044 (1.008-1.082) 1.015 (0.976-1.056) Without age adjustment 18 1.211 (1.101-1.331) 1.168 (1.061-1.285) 1.131 (1.018-1.256) Case-control studies 77 1.106 (1.064-1.150) 1.066 (1.025-1.109) 1.034 (0.991-1.080) Prospective studies 16 1.081 (1.021-1.145) 1.043 (0.985-1.105) 1.018 (0.957-1.083)